Total number of publications: 143
2024
-
RAS mutation specific survival in patients with metastatic colorectal cancer treated with trifluridine/tipiracil.
Year: 2024, type: Conference abstract
2023
-
Primary Breast Sarcoma: A Two-Centre Analysis and Review of Literature
BREAST CARE, year: 2023, volume: 18, edition: 4, DOI
2022
-
Role of miR-653 and miR-29c in downregulation of CYP1A2 expression in hepatocellular carcinoma
Pharmacological Reports, year: 2022, volume: 74, edition: 1, DOI
2021
-
41P Predicting response to checkpoint inhibitors using complex molecular characteristics and immunoprofiling in solid tumours
Year: 2021, type: Conference abstract
-
An Independent Validation Study of Candidate microRNAs as Predictive Biomarkers for Bevacizumab-based Therapy in Patients With Metastatic Colorectal Cancer
In vivo, year: 2021, volume: 35, edition: 5, DOI
-
Nádory neznámé primární lokalizace.
Year: 2021, type:
-
Neoadjuvant Chemotherapy of Triple-Negative Breast Cancer: Evaluation of Early Clinical Response, Pathological Complete Response Rates, and Addition of Platinum Salts Benefit Based on Real-World Evidence
Cancers, year: 2021, volume: 13, edition: 7, DOI
-
Predikce odpovědi na léčbu imunoterapiícheckpoint inhibitory u pacientů s pokročilýmisolidními nádory
Klinicka Onkologie, year: 2021, edition: 34 (Suppl 2)
-
The use of cisplatin in patients after kidney transplantation with chronic renal insufficiency Is the benefit higher than potential risks in therapy of non-seminomatous germ cell tumors?
Medicine, year: 2021, volume: 100, edition: 24, DOI
2020
-
Comprehensive Molecular Profiling for Relapsed/Refractory Pediatric Burkitt Lymphomas-Retrospective Analysis of Three Real-Life Clinical Cases-Addressing Issues on Randomization and Customization at the Bedside
Frontiers in Oncology, year: 2020, volume: 9, edition: FEB 2020, DOI